Study: Merck Arcoxia Cox-2 shows fewer side effects than NSAID

02/8/2007 | Reuters

New research shows Merck's Arcoxia, a Cox-2 inhibitor for killing pain, has fewer side effects than the NSAID diclofenac, with which it was compared. The study said Arcoxia caused fewer stomach disorders and complications than diclofenac.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ
RN Care Manager
Brooklyn, NY
Director of Utilization Management
Meridian Health Plan
Chicago, IL
Senior Manager, Healthcare Reform
Avalere Health
Washington, DC